British Journal of Dermatology

RESEARCH SNIPPETS
pp. i-i(1)

Sunbeds, beauty and melanoma
pp. 215-216(2)
Author: Diffey, Brian

Proposal of a new classification system for melanocytic naevi
pp. 217-227(11)
Authors: Argenziano, G.; Zalaudek, I.; Ferrara, G.; Hofmann-Wellenhof, R.; Soyer, H.P.

The oncogenic potential of human papillomaviruses: a review on the role of host genetics and environmental cofactors
pp. 228-241(14)
Authors: Madkan, V.K.; Cook-Norris, R.H.; Steadman, M.C.; Arora, A.; Mendoza, N.; Tyring, S.K.

Mechanisms of melanogenesis inhibition by 2,5-dimethyl-4-hydroxy-3(2H)-furanone
pp. 242-248(7)
Authors: Lee, J.; Jung, E.; Huh, S.; Boo, Y.C.; Hyun, C.G.; Kim, Y-S.; Park, D.

Antitumour necrosis factor-α chimeric antibody (infliximab) inhibits activation of skin-homing CD4+ and CD8+ T lymphocytes and impairs dendritic cell function
pp. 249-258(10)
Authors: Bedini, C.; Nasorri, F.; Girolomoni, G.; Pità, O. de; Cavani, A.

Adhesion of peripheral blood mononuclear cells and CD4+ T cells from patients with psoriasis to cultured endothelial cells via the interaction between lymphocyte function-associated antigen type 1 and intercellular adhesion molecule 1
pp. 259-265(7)
Authors: Watabe, D.; Kanno, H.; Yoshida, A.; Kurose, A.; Akasaka, T.; Sawai, T.

Dermoscopic pattern of intermediate stage in seborrhoeic keratosis regressing to lichenoid keratosis: report of 24 cases
pp. 266-272(7)
Authors: Zaballos, P.; Blazquez, S.; Puig, S.; Salsench, E.; Rodero, J.; Vives, J.M.; Malvehy, J.

Long-term culture of multibacillary leprosy macrophages isolated from skin lesions: a new model to study Mycobacterium leprae-human cell interaction
pp. 273-283(11)
Authors: Moura, D.F.; Teles, R.M.B.; Ribeiro-Carvalho, M.M.; Teles, R.B.; Santos, I.M.C.F.; Ferreira, H.; Fulco, T.O.; Nery, J.A.C.; Sampaio, E.P.; Sarno, E.N.

Transformed mycosis fungoides: clinicopathological features and outcome
pp. 284-289(6)
Authors: Barberio, E.; Thomas, L.; Skowron, F.; Balme, B.; Dalle, S.

Men with Kennedy disease have a reduced risk of androgenetic alopecia
pp. 290-294(5)
Authors: Sinclair, R.; Greenland, K.J.; Egmond, S. van; Hoedemaker, C.; Chapman, A.; Zajac, J.D.

Fragrance ingredient labelling in products on sale in the U.K.
pp. 295-300(6)
Author: Buckley, D.A.

Use of complementary and alternative treatment for allergic contact dermatitis
pp. 301-305(5)
Authors: Noiesen, E.; Munk, M.D.; Larsen, K.; Høyen, M.; Agner, T.

Alteration of extracellular matrix modulators after nonablative laser therapy in skin rejuvenation
pp. 306-310(5)
Authors: Oh, J.; Kim, N.; Seo, S.; Kim, I-H.

Acral lentiginous melanoma: histopathological prognostic features of 121 cases
pp. 311-318(8)
Authors: Phan, A.; Touzet, S.; Dalle, S.; Ronger-Savlé, S.; Balme, B.; Thomas, L.

Stromelysin-3 expression in the differential diagnosis of dermatofibroma and dermatofibrosarcoma protuberans: comparison with factor XIIIa and CD34
pp. 319-324(6)
Authors: Kim, H.J.; Lee, J.Y.; Kim, S.H.; Seo, Y.J.; Lee, J.H.; Park, J.K.; Kim, M.H.; Cinn, Y.W.; Cho, K.H.; Yoon, T.Y.

A study of the secretion mechanism of the sebaceous gland using three-dimensional reconstruction to examine the morphological relationship between the sebaceous gland and the arrector pili muscle in the follicular unit
pp. 325-330(6)
Authors: Song, W-C.; Hu, K-S.; Kim, H-J.; Koh, K-S.

Fabry disease and the skin: data from FOS, the Fabry outcome survey
pp. 331-337(7)
Authors: Orteu, C.H.; Jansen, T.; Lidove, O.; Jaussaud, R.; Hughes, D.A.; Pintos-Morell, G.; Ramaswami, U.; Parini, R.; Sunder-Plassman, G.; Beck, M.; Mehta, A.B.

Trends in melanoma epidemiology suggest three different types of melanoma
pp. 338-343(6)
Authors: Lipsker, D.; Engel, F.; Cribier, B.; Velten, M.; Hedelin, G.

The challenge of follow-up in narrowband ultraviolet B phototherapy
pp. 344-349(6)
Authors: Diffey, B.L.; Farr, P.M.

Quantitative risk assessment of sunbeds: impact of new high power lamps
pp. 350-356(7)
Authors: Oliver, H.; Ferguson, J.; Moseley, H.

Efficacy and tolerability of a Chinese herbal medicine concoction for treatment of atopic dermatitis: a randomized, double-blind, placebo-controlled study
pp. 357-363(7)
Authors: Hon, K.L.E.; Leung, T.F.; Ng, P.C.; Lam, M.C.A.; Kam, W.Y.C.; Wong, K.Y.; Lee, K.C.K.; Sung, Y.T.; Cheng, K.F.; Fok, T.F.; Fung, K.P.; Leung, P.C.

Combination of surgical avulsion and topical therapy for single nail onychomycosis: a randomized controlled trial
pp. 364-368(5)
Authors: Grover, C.; Bansal, S.; Nanda, S.; Reddy, B.S.N.; Kumar, V.

Topical becocalcidiol for the treatment of psoriasis vulgaris: a randomized, placebo-controlled, double-blind, multicentre study
pp. 369-374(6)
Authors: Helfrich, Y.R.; Kang, S.; Hamilton, T.A.; Voorhees, J.J.

No association between MDM2 SNP309 promoter polymorphism and basal cell carcinoma of the skin
pp. 375-377(3)
Authors: Wilkening, S.; Hemminki, K.; Rudnai, P.; Gurzau, E.; Koppova, K.; Försti, A.; Kumar, R.

Addition of topical pimecrolimus to once-daily mid-potent steroid confers no short-term therapeutic benefit in the treatment of severe atopic dermatitis; a randomized controlled trial
pp. 378-381(4)
Authors: Spergel, J.M.; Boguniewicz, M.; Paller, A.S.; Hebert, A.A.; Gallagher, P.R.; McCormick, C.; Parneix-Spake, A.; Hultsch, T.

Multiple eruptive myxoid dermatofibromas: report of first case and review of literature
pp. 382-385(4)
Authors: Antal, A.; Zelger, B.; Reifenberger, J.; Niehues, T.; Feyen, O.; Megahed, M.; Ruzicka, T.; Homey, B.

A novel mutation of the SLC39A4 gene causing acrodermatitis enteropathica
pp. 386-387(2)
Authors: Kilic, S. S; Giraud, M.; Schmitt, S.; Bézieau, S.; Küry, S.

Severe persistent pemphigoid gestationis: long-term remission with rituximab
pp. 388-389(2)
Authors: Cianchini, G.; Masini, C.; Lupi, F.; Corona, R.; DePità, O.; Puddu, P.

Livedo racemosa and digital necrosis in a patient with primary seronegative antiphospholipid syndrome and fibromuscular dysplasia of peripheral arteries
pp. 389-392(4)
Authors: Eisendle, K.; Jaschke, W.; Sepp, N.

Hypocomplementaemic urticarial vasculitis associated with non-Hodgkin lymphoma and treatment with intravenous immunoglobulin
pp. 392-393(2)
Authors: Shah, D.; Rowbottom, A.W.; Thomas, C.L.; Cumber, P.; Chowdhury, M.M.U.

Consecutive use of different biological therapies in the treatment of psoriasis
pp. 394-394(1)
Authors: Costanzo, A.; Papoutsaki, M.; Mazzotta, A.; Chimenti, S.

Cutaneous mercury deposits after henna dye application in the arm
pp. 394-395(2)
Authors: Mouzopoulos, G.; Tsouparopoulos, V.; Stamatakos, M.; Mihelarakis, I.; Pasparakis, D.; Agapitos, E.

Development of Crohn disease in a patient on etanercept for psoriasis
pp. 396-396(1)
Authors: Ahmad, K.; Rogers, S.

Leptomeningeal melanoma and multiple cutaneous melanocytic naevi
pp. 397-398(2)
Authors: Ponnampalam, J.; Nicholson, J.; Atherton, D.

Fibronectin and laminin expression in sentinel lymph nodes of patients with malignant melanoma
pp. 398-401(4)
Authors: Gradilone, A.; Gazzaniga, P.; Cigna, E.; Vasaturo, F.; Vincenzi, B.; Gandini, O.; Silvestri, I.; Ribuffo, D.; Scarpa, S.; Scuderi, N.; Aglianò, A.M.

A randomized study of minimal curettage followed by topical photodynamic therapy compared with surgical excision for low-risk nodular basal cell carcinoma
pp. 401-403(3)
Authors: Berroeta, L.; Clark, C.; Dawe, R.S.; Ibbotson, S.H.; Fleming, C.J.

Lymphocytic infiltration (Jessner-Kanof): lupus erythematosus tumidus or a manifestation of borreliosis?
pp. 403-405(3)
Authors: Kaatz, M.; Zelger, B.; Norgauer, J.; Ziemer, M.

Prognostic value of sentinel lymph node biopsy
pp. 405-405(1)
Authors: Shaw, H.M.; Thompson, J.F.

Granulomatous slack skin with clonal T-cell receptor-γ gene rearrangement in skin and lymph node
pp. 405-407(3)
Authors: Belousova, I.E.; Nikonova, S.M.; Sima, R.; Kazakov, D.V.

Fatal disseminated angioinvasive Fusarium falciforme infection in a patient with acute myeloid leukaemia
pp. 407-409(3)
Authors: Yun, S.J.; Shin, M-G.; Choi, C.; Kim, H-J.; Lee, J-B.; Kim, S-J.; Lee, S-C.; Won, Y.H.

Maximizing the quality of review articles
pp. 409-409(1)
Authors: Sladden, M.J.; Sladden, C.S.

Erythrokeratoderma variabilis without GJB3 or GJB4 mutation: a review of Japanese patients
pp. 410-411(2)
Authors: Ishikawa, O.; Nakamura, M.

Lichen sclerosus et atrophicus-like lesions in mycosis fungoides
pp. 411-413(3)
Authors: Parera, E.; Toll, A.; Gallardo, F.; Bellosillo, B.; Pujol, R.M.; Martí, R.

Does spontaneous autoimmunity improve survival in visceral metastatic melanoma?
pp. 413-415(3)
Authors: Vercambre-Darras, S.; Dubucquoi, S.; Fajardy, I.; Piette, F.; Mortier, L.

Filaggrin expression and the pathogenesis of epidermal cysts
pp. 415-416(2)
Authors: Kurokawa, I.; Umeda, K.; Nishimura, K.; Yamanaka, K-I.; Hakamada, A.; Isoda, K-I.; Tsubura, A.; Mizutani, H.

Treatment-resistant classical epidermolysis bullosa acquisita responding to rituximab
pp. 417-419(3)
Authors: Sadler, E.; Schafleitner, B.; Lanschuetzer, C.; Laimer, M.; Pohla-Gubo, G.; Hametner, R.; Hintner, H.; Bauer, J.W.

Urachal sinus presenting as periumbilical dermatitis
pp. 419-420(2)
Authors: Cox, G.A.; Chan, I.; Lloyd, J.; Witherow, R.O.; Leonard, J.N.

Ciclosporin improves quality of life in Kimura's disease
pp. 420-421(2)
Authors: Vourc'h, M.; Barbarot, S.; Stalder, J.-F.

Treatment of lentigo maligna with topical 1% cidofovir
pp. 421-423(3)
Author: Calista, D.

Serum tissue polypeptide antigen correlating with clinical course in a patient with mycosis fungoides: a potential disease marker?
pp. 423-425(3)
Authors: Hu, S.C-S.; Chen, G-S.; Wu, C-S.; Lan, C-C.E.

On confusing prima facie validity with true validity
pp. 425-426(2)
Authors: Berger, V.W.; Gee, E.

Lymphomatoid granulomatosis complicating other haematological malignancies
pp. 426-429(4)
Authors: Muller, F.M.; Lewis-Jones, S.; Morley, S.; Kernohan, N.; MeikleJohn, D.; Goodlad, J.R.; Evans, A.

Book Review
pp. 429-430(2)
Author: Anstey, A.V.

News and Notices
pp. 430-431(2)

Corrigenda
pp. 431-431(1)

Corrigenda
pp. 431-431(1)